Literature DB >> 8118690

Glucagon and the paraventricular hypothalamus: modulation of energy balance.

D M Atrens1, J A Menéndez.   

Abstract

The effects of glucagon injections (25, 100 and 200 ng) into the paraventricular nucleus of the hypothalamus (PVN) were investigated in an open-circuit calorimeter. Wistar rats were tested, with no food available during the tests. High doses of glucagon (100 and 200 ng) produced small and short-lasting increases in energy expenditure. The independence of these changes from changes in locomotor activity suggests that the thermogenesis represents a primary modulation and is not secondary to increased locomotion. All three doses of glucagon produced long-lasting and dose-related increases in respiratory quotient which were unrelated to any changes in locomotor activity. As with the changes in energy expenditure, this dissociation indicates that the effects are not secondary to changes in locomotor activity. These data constitute the first evidence that glucagon in the PVN modulates the metabolic parameters central to energy balance. In separate experiments, the three doses of glucagon increased blood glucose concentration over a one hour period, but they did not affect food and water intake and body weight over 24 h. These findings suggest that glucagon normally acts on the PVN in conditions of increased body fat to initiate autonomic mechanisms which increase glycemic levels, thermogenesis and carbohydrate utilization. These data constitute the first direct evidence for the involvement of the PVN in the regulation of energy balance by glucagon. The main effect of glucagon in the PVN is anabolic in that it increases dependence on carbohydrates as an energy substrate which results in a sparing of fat reserves.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8118690     DOI: 10.1016/0006-8993(93)90663-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Insulin and glucagon signaling in the central nervous system.

Authors:  Beatrice M Filippi; Mona A Abraham; Jessica T Y Yue; Tony K T Lam
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

2.  Glucagon's yin and yang effects on hepatic glucose production.

Authors:  Dale S Edgerton; Alan D Cherrington
Journal:  Nat Med       Date:  2013-06       Impact factor: 53.440

Review 3.  Glucagon-related peptides and the regulation of food intake in chickens.

Authors:  Kazuhisa Honda
Journal:  Anim Sci J       Date:  2016-05-06       Impact factor: 1.749

4.  Oxyntomodulin analogue increases energy expenditure via the glucagon receptor.

Authors:  R Scott; J Minnion; T Tan; S R Bloom
Journal:  Peptides       Date:  2018-04-20       Impact factor: 3.750

5.  The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice.

Authors:  Jacqueline L Beaudry; Kiran Deep Kaur; Elodie M Varin; Laurie L Baggio; Xiemin Cao; Erin E Mulvihill; Jennifer H Stern; Jonathan E Campbell; Phillip E Scherer; Daniel J Drucker
Journal:  Mol Metab       Date:  2019-02-05       Impact factor: 7.422

6.  Green Tea Polyphenol (-)-Epigallocatechin Gallate (EGCG) Attenuates Neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced Obese Mice.

Authors:  Limin Mao; Danielle Hochstetter; Liyun Yao; Yueling Zhao; Jihong Zhou; Yuefei Wang; Ping Xu
Journal:  Int J Mol Sci       Date:  2019-10-13       Impact factor: 5.923

Review 7.  Glucagon Control on Food Intake and Energy Balance.

Authors:  Omar Al-Massadi; Johan Fernø; Carlos Diéguez; Ruben Nogueiras; Mar Quiñones
Journal:  Int J Mol Sci       Date:  2019-08-11       Impact factor: 5.923

Review 8.  Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes.

Authors:  Brian Finan; Megan E Capozzi; Jonathan E Campbell
Journal:  Diabetes       Date:  2019-06-09       Impact factor: 9.461

Review 9.  Glucagon Regulation of Energy Expenditure.

Authors:  Maximilian Kleinert; Stephan Sachs; Kirk M Habegger; Susanna M Hofmann; Timo D Müller
Journal:  Int J Mol Sci       Date:  2019-10-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.